Dr. Timothy G. Berger, MD

Dr. Berger practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Berger's NPI, 1124079181, was assigned on May 15, 2006. Dr. Berger graduated from UT Southwestern Medical Center in 1975. Dr. Berger holds California license G32599.

Dr. Berger's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Berger's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Berger to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berger practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Berger's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Berger is board certified in dermatology by the American Board of Dermatology. Dr. Berger is licensed in California.

Dmand AI lists acne, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes, psoriasis and rash among the conditions Dr. Berger treats.

CMS data shows 526 Medicare services from Dr. Berger across 11 procedure codes in 2024, for 149 Medicare patients. Medicare paid $27,732 for them. Every service was in an office.

CMS counts 149 Medicare patients who saw Dr. Berger in 2024. The largest group is 75 to 84, with 62 patients. 68% of them have high cholesterol, and 60% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Berger's median patient age at 68, with 50% women.

In 2024, Dr. Berger wrote 1,104 Medicare Part D claims for 182 patients. 82% of them were for generic drugs. CMS names the drug for 892 of them, across 28 drugs with 11 or more claims each, at $775,480 in total drug cost. In 2023, CMS named 996 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Berger for performance year 2024, reported as part of a group. Dr. Berger accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Berger as offering telehealth. CMS counts 70 procedures of removal of skin lesions by Dr. Berger, more than 73% of the clinicians it reports for that procedure.

Dmand AI links 178 papers to Dr. Berger, published from 2002 to 2024. 2019 was the busiest year, with 7. The most frequent topics are Acquired Immunodeficiency Syndrome, HIV Infections and Skin Neoplasms. Dr. Berger has published most often in J Am Acad Dermatol. Dr. Berger's most frequent co-authors are Philip Emanuel Leboit, MD, Jane E. Koehler, MD and John Y.m. Koo, MD.

Dmand AI links Dr. Berger to 1 clinical trial. Conditions studied include Dermatitis, Atopic and Skin Diseases, Eczematous. Open Payments lists research payments to Dr. Berger that name 1 trial.

CMS Open Payments shows 104 general payments to Dr. Berger from 9 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Sanofi and Genzyme US Companies paid the most, $158,117. It also lists 4 research payments totaling $8,025 from 2018 to 2019, naming 1 clinical trial.

Dmand AI lists 5 awards for Dr. Berger, most recently Regional Top Doctor in 2014.

Dr. Berger graduated from UT Southwestern Medical Center in 1975. Dr. Berger is a member of AAD.

Dr. Berger is in network with 8 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.